News | March 05, 2024
Biocon Biologics secures Canada market entry date for YESAFILI
This agreement paves the way for the introduction of YESAFILI into the Canadian market
This agreement paves the way for the introduction of YESAFILI into the Canadian market
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Currently, Venkat is Lead – Market Access, India at Pfizer
Subscribe To Our Newsletter & Stay Updated
